期刊文献+

2012-2014年辽宁省大连市某医院分离粪肠球菌耐药性及多位点序列分析 被引量:4

Antibiotic susceptibility and multi locus sequence type of Enterococcus faecalis strains isolated from patients of a hospital in Dalian
原文传递
导出
摘要 目的了解大连市某医院2012-2014年住院患者分离粪肠球菌耐药性、携带毒力基因情况和多位点序列分型(MLST)的型别。方法使用自动化仪器法对分离菌株的耐药性进行鉴定。应用聚合酶链式反应(PCR)方法检测4种常见毒力基因的携带情况。应用MLST对分离菌株进行分型。结果分离的55株粪肠球菌中耐药菌株比例为92.72%,其中多重耐药菌的比例为65.45%。分离的粪肠球菌对四环素的耐药率最高,对红霉素、高浓度庆大霉素和利福平也有较高的耐药率。对青霉素耐药率为7.27%,未发现对糖肽类和脂肽类抗生素耐药的菌株。55株粪肠球菌共有28个MLST型别,其中CC(Clonal complex)16为优势克隆群,占菌株总数的43.64%。有多株同一克隆群的粪肠球菌具有相似的耐药谱和毒力携带情况。结论大连市某医院分离到多株属于同一克隆、多重耐药且携带多种毒力基因的粪肠球菌,需要针对优势克隆菌株的特点指导临床用药和院内感染的预防控制。 Objective To investigate antibiotic resistance,virulence genes,and sequence types of Enterococcus faecalisstrains isolated from patients in a hospital in Dalian,Liaoning province.Methods The antibiotic resistance of the E. faecalisisolated were detected with auto device. Polymerase chain reaction(PCR)was conducted for the four virulence genes of thestrains,and multi locus sequence typing(MLST)were performed to identify the sequence types of the E. faecals strains.Results A total of 55 E. faecalis strains isolated from the patients. Up to 92.72% of the strains were antibiotic resistant,and65.45% of the stains were multi drug resistant. The strains' resistances to 14 antibiotics were tested,the resistance totetracycline was highest,followed by that to erythromycin,high-concentration gentamicin and rifampicin. The resistant rate topenicillin was 7.27%,and no E. faecalis strains resistant to glycopeptide and lipopeptide antibiotics were detected. Twenty eightsequence types(STs)were detected in 55 E. faecalis strains,and CC16 was the major clonal complex including 43.64% of theE. faecalis strains. The characteristics of antibiotic resistance and virulence genes were similar in the E. faecalis isolates withsame STs.Conclusion The same clonal complex E. faecalis strains isolated from the patients of a hospital in Dalian sharedsimilar virulence genes and multi drug resistant pattern. The result can be used to guide clinical antibiotic use and nosocomialinfection control targeting predominant clonal complex of E. faecalis.
作者 李岩 王晶 张桂 杨晶 金东 Dalian Li Yan;Wang Jing;Zhang Gui;Yang Jing;Jin Dong(Department of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning, China;State Key Laboratory of Communicable Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China)
出处 《疾病监测》 CAS 2018年第5期391-396,共6页 Disease Surveillance
关键词 粪肠球菌 耐药性 毒力基因 多位点序列分型 Enterococcusfaecalis Antimicrobial susceptibility Virulence gene Multilocus sequence typing
  • 相关文献

参考文献4

  • 1胡付品,朱德妹,汪复,蒋晓飞,孙自镛,陈中举,胡志东,李金,谢轶,康梅,徐英春,张小江,张朝霞,季萍,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,储云卓,田素飞,徐元宏,沈继录,单斌,杜艳,卓超,苏丹虹,张泓,孔菁,魏莲花,吴玲,胡云建,艾效曼.2013年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2014,14(5):365-374. 被引量:622
  • 2胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,韩艳秋,郭素芳,魏莲花,吴玲,张泓,孔菁,胡云建,艾效曼,卓超,苏丹虹.2014年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2015,15(5):401-410. 被引量:727
  • 3胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,吴玲,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍.2015年CHINET细菌耐药性监测[J].中国感染与化疗杂志,2016,16(6):685-694. 被引量:390
  • 4杨晶,王红,张桂,熊衍文,金东.自贡市肉及其制品中粪肠球菌耐药性毒力基因和多位点序列分析[J].中国食品卫生杂志,2017,29(3):277-282. 被引量:5

二级参考文献30

  • 1Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 3Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 4Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.
  • 5Chen S. Hu F. Zhang X. et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatrnentj]]. J Clin Microbiol , 2011. 49( 11): 4022- 4023.
  • 6van Duin D. Kaye KS. Neuner EA. et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes[J]. Diagn Microbiol Infect Dis. 2013. 75(2): l1S-120.
  • 7Daikos GL. Tsaousi S. Tzouvelekis LS. et al. Carbapenemaseproducing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems [J]. Antimicrob Agents Chernother , 2014.58 (4): 2322-2328.
  • 8Tascini C. Tagliaferri E. Giani T. et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPCproducing Klebsiella pneumoniae [J]. Antimicrob Agents Chernother , 2013. 57 (8): 3990-3993.
  • 9Pulcini C. Bush K. Craig WA. et al. Forgotten Antibiotics: an Inventory in Europe. the United States. Canada. and Australia[J]. Clin Infect Dis. 2012. 54(2): 268-274.
  • 10Falagas ME. Giannopoulou KP. Kokolakis GN. et al. Fosfomycin , use beyond urinary tract and gastrointestinal infections [J]. Clin Infect Dis. 2008. 46(7): 1069-1077.

共引文献1501

同被引文献15

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部